- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03451474
Restoring Hand Function Utilizing Nerve Transfers in Persons With Cervical Spinal Cord Injuries
October 13, 2021 updated by: The University of Texas Health Science Center, Houston
The primary objective of this study is to evaluate the safety and efficacy of nerve transfer surgery for restoring hand function as a therapy for patients with cervical spinal cord injury.
Study Overview
Status
Terminated
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
3
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- The University of Texas Health Science Center at Houston
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- American Spinal Injury Association (ASIA) grade of A, B, or C, or with a diagnosis of central cord syndrome, showing minimal to no evidence of functional improvement in motor examination after at least 6 months of non-operative therapy post-injury
- >6 months post-injury
- International Classification of Surgery of the Hand in Tetraplegia (ICSHT) category 0-4
- Cervical spinal cord injury resulting in arm & hand functional impairment, with at least preserved elbow flexion
- Physically and mentally willing and able to comply with study protocol
- Lives in the immediate area and has no plans to relocate
- Provides informed consent and HIPAA release of medical information
Exclusion Criteria:
- Active infection
- Any return or ongoing clinical recovery of distal motor function within 6 months after injury
- Physically/mentally compromised
- Systemic disease that would affect the patient's welfare or the research study
- Immunologically suppressed or immunocompromised
- Currently undergoing long-term steroid therapy
- Active malignancy
- Pending litigation or receiving Workers Compensation related to injury or accident
- Pregnancy
- Significant contractures and/or limitations in passive range of motion in the arm or hand
- Poorly controlled upper extremity spasticity
- Uncontrolled pain or hypersensitivity
- Previous or current injury preventing use of tendon transfers to restore upper extremity function
- History of brachial plexus injury or systemic neuropathic process
- In the opinion of the Principal Investigator the subject would not be a candidate for the procedure
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Upper extremity nerve transfer surgery
Upper extremity nerve transfer surgery is a surgical procedure where axons from an intact, functioning upper extremity peripheral nerve are moved to a target muscle that demonstrates significant weakness or paralysis as a result of spinal cord injury.
After allowing time for recovery from surgery and for nerve growth to occur, the patient undergoes hand/occupational therapy in order to retrain motor skills.
|
Upper extremity nerve transfer surgery is a surgical procedure where axons from an intact, functioning upper extremity peripheral nerve are moved to a target muscle that demonstrates significant weakness or paralysis as a result of spinal cord injury.
After allowing time for recovery from surgery and for nerve growth to occur, the patient undergoes hand/occupational therapy in order to retrain motor skills.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Upper extremity muscle strength of right arm as assessed by the Graded Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP) strength subscale
Time Frame: Pre-operative
|
The GRASSP is a measure of upper extremity strength, sensation, and grip that is specific to patients with tetraplegia.
It consists of 5 subscales for each upper extremity, and this measure will report the strength subscale (manual muscle testing of 10 muscles in right arm - subscale total score encompasses all 10 muscles).
The strength subscale total score ranges from 0 to 50.
The GRASSP will be administered by the nurses or physical therapist involved in the study.
|
Pre-operative
|
Upper extremity muscle strength of right arm as assessed by the Graded Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP) strength subscale
Time Frame: post-operative at 2 weeks
|
The GRASSP is a measure of upper extremity strength, sensation, and grip that is specific to patients with tetraplegia.
It consists of 5 subscales for each upper extremity, and this measure will report the strength subscale (manual muscle testing of 10 muscles in right arm - subscale total score encompasses all 10 muscles).
The strength subscale total score ranges from 0 to 50.
The GRASSP will be administered by the nurses or physical therapist involved in the study.
|
post-operative at 2 weeks
|
Upper extremity muscle strength of right arm as assessed by the Graded Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP) strength subscale
Time Frame: post-operative at 3 months
|
The GRASSP is a measure of upper extremity strength, sensation, and grip that is specific to patients with tetraplegia.
It consists of 5 subscales for each upper extremity, and this measure will report the strength subscale (manual muscle testing of 10 muscles in right arm - subscale total score encompasses all 10 muscles).
The strength subscale total score ranges from 0 to 50.
The GRASSP will be administered by the nurses or physical therapist involved in the study.
|
post-operative at 3 months
|
Upper extremity muscle strength of right arm as assessed by the Graded Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP) strength subscale
Time Frame: post-operative at 6 months
|
The GRASSP is a measure of upper extremity strength, sensation, and grip that is specific to patients with tetraplegia.
It consists of 5 subscales for each upper extremity, and this measure will report the strength subscale (manual muscle testing of 10 muscles in right arm - subscale total score encompasses all 10 muscles).
The strength subscale total score ranges from 0 to 50.
The GRASSP will be administered by the nurses or physical therapist involved in the study.
|
post-operative at 6 months
|
Upper extremity muscle strength of right arm as assessed by the Graded Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP) strength subscale
Time Frame: post-operative at 12 months
|
The GRASSP is a measure of upper extremity strength, sensation, and grip that is specific to patients with tetraplegia.
It consists of 5 subscales for each upper extremity, and this measure will report the strength subscale (manual muscle testing of 10 muscles in right arm - subscale total score encompasses all 10 muscles).
The strength subscale total score ranges from 0 to 50.
The GRASSP will be administered by the nurses or physical therapist involved in the study.
|
post-operative at 12 months
|
Upper extremity muscle strength of right arm as assessed by the Graded Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP) strength subscale
Time Frame: post-operative at 24 months
|
e GRASSP is a measure of upper extremity strength, sensation, and grip that is specific to patients with tetraplegia.
It consists of 5 subscales for each upper extremity, and this measure will report the strength subscale (manual muscle testing of 10 muscles in right arm - subscale total score encompasses all 10 muscles).
The strength subscale total score ranges from 0 to 50.
The GRASSP will be administered by the nurses or physical therapist involved in the study.
|
post-operative at 24 months
|
Upper extremity muscle strength of left arm as assessed by the Graded Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP) strength subscale
Time Frame: Pre-operative
|
The GRASSP is a measure of upper extremity strength, sensation, and grip that is specific to patients with tetraplegia.
It consists of 5 subscales for each upper extremity, and this measure will report the strength subscale (manual muscle testing of 10 muscles in left arm - subscale total score encompasses all 10 muscles).
The strength subscale total score ranges from 0 to 50.
The GRASSP will be administered by the nurses or physical therapist involved in the study.
|
Pre-operative
|
Upper extremity muscle strength of left arm as assessed by the Graded Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP) strength subscale
Time Frame: post-operative at 2 weeks
|
The GRASSP is a measure of upper extremity strength, sensation, and grip that is specific to patients with tetraplegia.
It consists of 5 subscales for each upper extremity, and this measure will report the strength subscale (manual muscle testing of 10 muscles in right arm - subscale total score encompasses all 10 muscles).
The strength subscale total score ranges from 0 to 50.
The GRASSP will be administered by the nurses or physical therapist involved in the study.
|
post-operative at 2 weeks
|
Upper extremity muscle strength of left arm as assessed by the Graded Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP) strength subscale
Time Frame: post-operative at 3 months
|
The GRASSP is a measure of upper extremity strength, sensation, and grip that is specific to patients with tetraplegia.
It consists of 5 subscales for each upper extremity, and this measure will report the strength subscale (manual muscle testing of 10 muscles in right arm - subscale total score encompasses all 10 muscles).
The strength subscale total score ranges from 0 to 50.
The GRASSP will be administered by the nurses or physical therapist involved in the study.
|
post-operative at 3 months
|
Upper extremity muscle strength of left arm as assessed by the Graded Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP) strength subscale
Time Frame: post-operative at 6 months
|
The GRASSP is a measure of upper extremity strength, sensation, and grip that is specific to patients with tetraplegia.
It consists of 5 subscales for each upper extremity, and this measure will report the strength subscale (manual muscle testing of 10 muscles in right arm - subscale total score encompasses all 10 muscles).
The strength subscale total score ranges from 0 to 50.
The GRASSP will be administered by the nurses or physical therapist involved in the study.
|
post-operative at 6 months
|
Upper extremity muscle strength of left arm as assessed by the Graded Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP) strength subscale
Time Frame: post-operative at 12 months
|
The GRASSP is a measure of upper extremity strength, sensation, and grip that is specific to patients with tetraplegia.
It consists of 5 subscales for each upper extremity, and this measure will report the strength subscale (manual muscle testing of 10 muscles in right arm - subscale total score encompasses all 10 muscles).
The strength subscale total score ranges from 0 to 50.
The GRASSP will be administered by the nurses or physical therapist involved in the study.
|
post-operative at 12 months
|
Upper extremity muscle strength of left arm as assessed by the Graded Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP) strength subscale
Time Frame: post-operative at 24 months
|
The GRASSP is a measure of upper extremity strength, sensation, and grip that is specific to patients with tetraplegia.
It consists of 5 subscales for each upper extremity, and this measure will report the strength subscale (manual muscle testing of 10 muscles in right arm - subscale total score encompasses all 10 muscles).
The strength subscale total score ranges from 0 to 50.
The GRASSP will be administered by the nurses or physical therapist involved in the study.
|
post-operative at 24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Motor neuron signaling as assessed by electromyography (EMG)
Time Frame: Pre-operative, post-operative at 6 months, 1 year, and 2 years
|
Quantitative assessment of motor neuron signalling
|
Pre-operative, post-operative at 6 months, 1 year, and 2 years
|
Strength as assessed by Manual Muscle Testing (MMT)
Time Frame: Pre-operative (5 repeated measurements over 2 months), post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
MMT will be assessed by the physicians, nurses, or physical therapist involved in the study.
|
Pre-operative (5 repeated measurements over 2 months), post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
Strength as assessed by Hand Held Dynamometry (HHD)
Time Frame: Pre-operative (5 repeated measurements over 2 months), post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
Hand held dynamometry (via a "make test") will be used to assess strength.
|
Pre-operative (5 repeated measurements over 2 months), post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
Strength as assessed by the American Spinal Injury Association (ASIA) Upper Extremity Motor Score (UEMS)
Time Frame: Pre-operative (5 repeated measurements over 2 months), post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
The ASIA UEMS is a sum of the motor scores for 5 key upper extremity muscles on both the right and left side (each key muscle is a functionally significant representation of a spinal cord segment).
The strength of each key muscle on both the right and left side is graded from 0 to 5, with total scores ranging from 0 to 50.The UEMS will be determined in accordance with the International Standards for Neurological Classification of SCI examination guidelines by the physicians, nurses, or physical therapist.
|
Pre-operative (5 repeated measurements over 2 months), post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
Dorsal sensation as assessed by the Graded Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP) dorsal sensation subscale
Time Frame: Pre-operative (5 repeated measurements over 2 months), post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
The GRASSP is a measure of upper extremity strength, sensation, and grip that is specific to patients with tetraplegia.
It consists of 5 subscales for each upper extremity: strength (manual muscle testing of 10 muscles in right and left arms - subscale total score encompasses all 10 muscles), dorsal sensation, palmar sensation (measured with Semmes-Weinstein monofilaments), qualitative grasp, and quantitative grasp.
Total score (which includes all subscale scores) ranges from 0 to 116 for each upper extremity (right or left arm).
The dorsal sensation subscale total score ranges from 0 to 12.
The GRASSP will be administered by the nurses or physical therapist involved in the study.
|
Pre-operative (5 repeated measurements over 2 months), post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
Palmar sensation as assessed by the Graded Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP) palmar sensation subscale
Time Frame: Pre-operative (5 repeated measurements over 2 months), post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
The GRASSP is a measure of upper extremity strength, sensation, and grip that is specific to patients with tetraplegia.
It consists of 5 subscales for each upper extremity: strength (manual muscle testing of 10 muscles in right and left arms - subscale total score encompasses all 10 muscles), dorsal sensation, palmar sensation (measured with Semmes-Weinstein monofilaments), qualitative grasp, and quantitative grasp.
Total score (which includes all subscale scores) ranges from 0 to 116 for each upper extremity (right or left arm).
The palmar sensation subscale total score ranges from 0 to 12.
The GRASSP will be administered by the nurses or physical therapist involved in the study.
|
Pre-operative (5 repeated measurements over 2 months), post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
Qualitative grasp as assessed by the Graded Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP) qualitative grasp subscale
Time Frame: Pre-operative (5 repeated measurements over 2 months), post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
The GRASSP is a measure of upper extremity strength, sensation, and grip that is specific to patients with tetraplegia.
It consists of 5 subscales for each upper extremity: strength (manual muscle testing of 10 muscles in right and left arms - subscale total score encompasses all 10 muscles), dorsal sensation, palmar sensation (measured with Semmes-Weinstein monofilaments), qualitative grasp, and quantitative grasp.
Total score (which includes all subscale scores) ranges from 0 to 116 for each upper extremity (right or left arm).
The qualitative grasp subscale total score ranges from 0 to 12.
The GRASSP will be administered by the nurses or physical therapist involved in the study.
|
Pre-operative (5 repeated measurements over 2 months), post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
Quantitative grasp as assessed by the Graded Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP) quantitative grasp subscale
Time Frame: Pre-operative (5 repeated measurements over 2 months), post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
The GRASSP is a measure of upper extremity strength, sensation, and grip that is specific to patients with tetraplegia.
It consists of 5 subscales for each upper extremity: strength (manual muscle testing of 10 muscles in right and left arms - subscale total score encompasses all 10 muscles), dorsal sensation, palmar sensation (measured with Semmes-Weinstein monofilaments), qualitative grasp, and quantitative grasp.
Total score (which includes all subscale scores) ranges from 0 to 116 for each upper extremity (right or left arm).
The quantitative grasp subscale total score ranges from 0 to 30.
The GRASSP will be administered by the nurses or physical therapist involved in the study.
|
Pre-operative (5 repeated measurements over 2 months), post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
Total Score on the Graded Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP) scale
Time Frame: Pre-operative (5 repeated measurements over 2 months), post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
The GRASSP is a measure of upper extremity strength, sensation, and grip that is specific to patients with tetraplegia.
It consists of 5 subscales for each upper extremity: strength (manual muscle testing of 10 muscles in right and left arms - subscale total score encompasses all 10 muscles), dorsal sensation, palmar sensation (measured with Semmes-Weinstein monofilaments), qualitative grasp, and quantitative grasp.
Total score (which includes all subscale scores) ranges from 0 to 116 for each upper extremity (right or left arm).
The GRASSP will be administered by the nurses or physical therapist involved in the study.
|
Pre-operative (5 repeated measurements over 2 months), post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
Function (self-care) as assessed by the Spinal Cord Independence Measure III Self Report (SCIM III SR) questionnaire
Time Frame: Pre-operative (5 repeated measurements over 2 months), post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
The SCIM III SR is a measure of independence with activities across 3 subscales: self-care, respiration and sphincter management, and mobility.
The self-care subscale ranges from 0 to 20.
|
Pre-operative (5 repeated measurements over 2 months), post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
Function (respiration and sphincter management) as assessed by the Spinal Cord Independence Measure III Self Report (SCIM III SR) questionnaire
Time Frame: Pre-operative (5 repeated measurements over 2 months), post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
The SCIM III SR is a measure of independence with activities across 3 subscales: self-care, respiration and sphincter management, and mobility.
The respiration and sphincter management subscale ranges from 0 to 40.
|
Pre-operative (5 repeated measurements over 2 months), post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
Function (mobility) as assessed by the Spinal Cord Independence Measure III Self Report (SCIM III SR) questionnaire
Time Frame: Pre-operative (5 repeated measurements over 2 months), post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
The SCIM III SR is a measure of independence with activities across 3 subscales: self-care, respiration and sphincter management, and mobility.
The mobility subscale ranges from 0 to 40.
|
Pre-operative (5 repeated measurements over 2 months), post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
Function as assessed total score on the Spinal Cord Independence Measure III Self Report (SCIM III SR) questionnaire
Time Frame: Pre-operative (5 repeated measurements over 2 months), post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
The SCIM III SR is a measure of independence with activities across 3 subscales: self-care, respiration and sphincter management, and mobility.
Total score ranges from 0 to 100( that is, the total score is the sum of scores on the three subscales).
|
Pre-operative (5 repeated measurements over 2 months), post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
Hand function as assessed by the Michigan Hand Questionnaire (MHQ) total score
Time Frame: Pre-operative, post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
The MHQ instrument is a 37 core questions, self-report questionnaire used to assess changes in hand function.
The MHQ requires subjects to rate their overall hand function, activities of daily living (ADLs), pain, work performance, aesthetics, and patient satisfaction with hand function.
Scores on each of the 6 subscales range from 0 to 100, and an overall MHQ score is calculated by averaging the scores of the 6 subscales.
The MHQ will be administered by the physicians or nurses involved in the study.
|
Pre-operative, post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
Hand function as assessed by the Sollerman Hand Function Test total score
Time Frame: Pre-operative, post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
The Sollerman Hand Function Test is a standardized performance test designed to measure handgrips needed for certain activities of daily living (ADLs), such as eating, driving, personal hygiene, and writing.
It includes multiple subtests that represent common handgrips and activities, completed using the hands both bilaterally and separately.
Scoring of each subtest takes into account the time taken to complete the task, level of difficulty displayed, and quality of performance using correct grips.
Scores range from 0 (task cannot be completed) - 4; a total score (0 - 80) is obtained from the sum of scores of all subtests.
|
Pre-operative, post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
Disability as assessed by the Disabilities of the Arm, Shoulder, and Hand (DASH) instrument total score
Time Frame: Pre-operative, post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
The DASH instrument is a 30-item, self-report questionnaire used to assess overall upper extremity function.
The DASH requires subjects to rate their ability to perform tasks using the upper extremities.
Individuals are instructed to report their ability to perform the tasks, regardless of which arm they use or what strategies they employ.
A single disability/symptom score is produced.
Scores range from 0-100, where a greater score indicates greater disability.
The DASH will be administered by the physicians, nurses, or physical therapist involved in the study.
|
Pre-operative, post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
Health-related Quality of Life as assessed by the Short Form 36 (SF-36) questionnaire total score
Time Frame: Pre-operative, post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
The SF-36 is a questionnaire designed to measure general health and quality of life across eight, scaled scores (vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, and mental health)--a total score will be reported.
The eight subscales are each given scores, which are the weighted sums of the questions in each subscale section, and each subscale score is directly transformed into a total score of 0-100 scale.
The lower the score the more disability,a and the higher the score the less disability (that is, a score of zero is equivalent to maximum disability, and a score of 100 is equivalent to no disability).
The SF-36 will be administered by the physicians, nurses, or physical therapist involved in the study.
|
Pre-operative, post-operative at 2 weeks, 3 months, 6 months, 12 months, and 24 months
|
Number of participants with intraoperative complications
Time Frame: 24 months
|
24 months
|
|
Number of participants with post-operative complications
Time Frame: 24 months
|
24 months
|
|
Number of participants who require reoperation
Time Frame: 24 months
|
24 months
|
|
Number of participants who receive the nerve transfer intervention soon after their spinal cord injury
Time Frame: at the time of the nerve transfer intervention
|
The nerve transfer intervention will be considered "soon" or "early" if it is less than 12 months after the spinal cord injury that the nerve transfer intervention is intended to treat.
This will be assessed at the time of the nerve transfer intervention.
|
at the time of the nerve transfer intervention
|
Number of participants with an improvement in hand function as determined by qualitative video analysis
Time Frame: Pre-operative, post-operative at 6, 12, and 24 months
|
Pre-operative, post-operative at 6, 12, and 24 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Wesley H Jones, MD, The University of Texas Health Science Center, Houston
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
April 1, 2018
Primary Completion (ACTUAL)
July 17, 2020
Study Completion (ACTUAL)
July 17, 2020
Study Registration Dates
First Submitted
February 8, 2018
First Submitted That Met QC Criteria
February 23, 2018
First Posted (ACTUAL)
March 1, 2018
Study Record Updates
Last Update Posted (ACTUAL)
October 21, 2021
Last Update Submitted That Met QC Criteria
October 13, 2021
Last Verified
October 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HSC-MS-17-0081
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Cord Injuries
-
Khon Kaen UniversityUnknownInjuries, Spinal Cord
-
Universidade do Vale do ParaíbaCompletedInjuries, Spinal Cord
-
InVivo TherapeuticsTerminated
-
Ekso BionicsBurke Medical Research InstituteCompletedInjuries, Spinal CordUnited States
-
ReWalk Robotics, Inc.Unknown
-
Shepherd Center, Atlanta GACompletedInjuries, Spinal Cord
-
Wroclaw Medical UniversityInstitute of Immunology and Experimental Therapy of the Polish Academy of... and other collaboratorsUnknownComplete Spinal Cord InjuriesPoland
-
M.D. Anderson Cancer CenterActive, not recruitingMetastatic Epidural Spinal Cord CompressionUnited States
Clinical Trials on Upper extremity nerve transfer surgery
-
Burke Medical Research InstituteMassachusetts General HospitalRecruitingSpinal Cord Injuries | Cervical Spinal Cord Injury | TetraplegiaUnited States
-
Dartmouth-Hitchcock Medical CenterDartmouth CollegeRecruitingCompartment Syndromes | Compartment Syndrome of Forearm | Compartment Syndrome of Lower LegUnited States
-
University of KentuckyTerminatedStrokeUnited States
-
Medical University of ViennaImperial College London; Shirley Ryan AbilityLabEnrolling by invitation
-
Siriraj HospitalLerdsin General HospitalCompleted
-
Riphah International UniversityRecruiting
-
US Department of Veterans AffairsMassachusetts Institute of TechnologyCompleted
-
Michael ReinhartLinkoeping University; Örebro University, Sweden; Region Örebro CountyCompletedHeart Diseases | Heart Diseases, Ischemic | Heart Disease, ValvularSweden
-
US Department of Veterans AffairsCompleted
-
University of Illinois at ChicagoShirley Ryan AbilityLabCompletedStroke | Hemiparesis